These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2521518)

  • 1. Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides.
    Lambert RW; Martin JA; Thomas GJ; Duncan IB; Hall MJ; Heimer EP
    J Med Chem; 1989 Feb; 32(2):367-74. PubMed ID: 2521518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of 5'-PAA and 5'-PFA phosphate esters of 2'-deoxyuridines.
    Bird RM; Broadhurst AV; Duncan IB; Hall MJ; Lambert RW; Wong-Kai-In P
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():201-5. PubMed ID: 2947889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of esters of phosphonoformic acid and their antiherpes activity.
    Norén JO; Helgstrand E; Johansson NG; Misiorny A; Stening G
    J Med Chem; 1983 Feb; 26(2):264-70. PubMed ID: 6298425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates.
    Charvet AS; Camplo M; Faury P; Graciet JC; Mourier N; Chermann JC; Kraus JL
    J Med Chem; 1994 Jul; 37(14):2216-23. PubMed ID: 8035429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
    Griengl H; Hayden W; Penn G; De Clercq E; Rosenwirth B
    J Med Chem; 1988 Sep; 31(9):1831-9. PubMed ID: 2842506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral activity of certain nucleoside 5'-phosphonoformate derivatives.
    Vaghefi MM; McKernan PA; Robins RK
    J Med Chem; 1986 Aug; 29(8):1389-93. PubMed ID: 3016264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).
    Villinger F; Genovesi EV; Gerstner DJ; Whyard TC; Knudsen RC
    Arch Virol; 1990; 115(3-4):163-84. PubMed ID: 2148081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of foscarnet and foscarnet esters as anti-influenza virus agents.
    Strid S; Ekström C; Datema R
    Chemotherapy; 1989; 35(1):69-76. PubMed ID: 2524368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antiviral properties of sterol phosphonoformates.
    Bailey JM; Lightfoote M; Lillehoj E; Nelson K
    Biochem Soc Trans; 1994 Aug; 22(3):353S. PubMed ID: 7529728
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro inhibition of human herpesvirus-6 by phosphonoformate.
    Streicher HZ; Hung CL; Ablashi DV; Hellman K; Saxinger C; Fullen J; Salahuddin SZ
    J Virol Methods; 1988 Sep; 21(1-4):301-4. PubMed ID: 2972736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1989; 40(2):213-85. PubMed ID: 2543994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
    Oberg B
    Pharmacol Ther; 1982; 19(3):387-415. PubMed ID: 6201932
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of phosphonoformic acid in herpes infections].
    Smejkal F; Otová B; Zikán V; Roubínek F
    Cesk Farm; 1992 Feb; 41(1):1-4. PubMed ID: 1316808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
    Baba M; Ito M; Shigeta S; De Clercq E
    Antimicrob Agents Chemother; 1984 Apr; 25(4):515-7. PubMed ID: 6329083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of Epstein-Barr virus replication by phosphonoformic acid.
    Datta AK; Hood RE
    Virology; 1981 Oct; 114(1):52-9. PubMed ID: 6269292
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and applications of phosphonoacetic derivatives.
    Davini E; Di Leo C; Norelli F; Zappelli P
    J Biotechnol; 1993 Apr; 28(2-3):321-38. PubMed ID: 7764051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
    Eriksson B; Oberg B
    Antimicrob Agents Chemother; 1979 Jun; 15(6):758-62. PubMed ID: 475360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.